Preeclampsia Foundation Introduces Resources to Aid Understanding of Preeclampsia Testing
On October 7, 2025, the Preeclampsia Foundation made a significant stride in maternal health by introducing two new resources aimed at improving understanding of predictive and diagnostic testing for preeclampsia. These tools, titled “Ask About Preeclampsia Tests,” include an informative explainer video and a handout available in both English and Spanish. Their mission is to clarify the importance of various tests recommended by healthcare providers during pregnancy.
Preeclampsia, along with related hypertensive disorders of pregnancy (HDP), affects approximately 5-8% of pregnancies, yet the underlying causes of this serious condition remain elusive. The only definitive way to treat preeclampsia is through the delivery of the baby and placenta. Alarmingly, the condition can also develop or worsen up to six weeks after childbirth. This poses a significant challenge for healthcare providers, who must accurately identify at-risk patients and make informed clinical decisions regarding HDP.
Eleni Tsigas, CEO of the Preeclampsia Foundation, highlighted that regular monitoring for preeclampsia includes blood pressure assessments, weight checks, and urine tests during typical prenatal visits. Additionally, physicians may order blood work to evaluate the functioning of the kidneys, liver, and placenta. Tsigas emphasized the community's need for a better understanding of why these tests are conducted: "We’re excited to introduce two new tools for patients and providers to use together to help bridge that gap."
In recent years, advancements in medical technology have led to the development of more precise molecular tests designed to predict and diagnose preeclampsia. Some of these tests assist in determining who might develop early-onset preeclampsia, while others help in diagnosing severe cases—a variant known for its potentially devastating outcomes for both mothers and infants. These innovations, however, add to an already limited arsenal available to healthcare professionals dealing with a pregnancy complication that poses real threats to maternal and fetal health.
The Preeclampsia Foundation involved its Medical Advisory Board, composed of top experts in predictive and diagnostic testing, as well as patient advisors in the development of these educational materials, ensuring they are rooted in evidence-based, patient-centric content.
For patients seeking information on preeclampsia testing, they can visit Preeclampsia's Patient Testing Resources. Healthcare providers can access resources tailored to their needs via Preeclampsia's Provider Testing Resources.
Established in 2000, the Preeclampsia Foundation is a U.S.-based non-profit organization dedicated to enhancing outcomes for those grappling with hypertensive disorders of pregnancy. Their goal is to educate, support, and engage the community while fostering improved healthcare practices and ultimately finding a cure for preeclampsia. Their vision is a world in which preeclampsia and related disorders do not pose risks to the lives of mothers and their babies. For more details about their initiatives, visit www.preeclampsia.org.
Preeclampsia, along with related hypertensive disorders of pregnancy (HDP), affects approximately 5-8% of pregnancies, yet the underlying causes of this serious condition remain elusive. The only definitive way to treat preeclampsia is through the delivery of the baby and placenta. Alarmingly, the condition can also develop or worsen up to six weeks after childbirth. This poses a significant challenge for healthcare providers, who must accurately identify at-risk patients and make informed clinical decisions regarding HDP.
Eleni Tsigas, CEO of the Preeclampsia Foundation, highlighted that regular monitoring for preeclampsia includes blood pressure assessments, weight checks, and urine tests during typical prenatal visits. Additionally, physicians may order blood work to evaluate the functioning of the kidneys, liver, and placenta. Tsigas emphasized the community's need for a better understanding of why these tests are conducted: "We’re excited to introduce two new tools for patients and providers to use together to help bridge that gap."
In recent years, advancements in medical technology have led to the development of more precise molecular tests designed to predict and diagnose preeclampsia. Some of these tests assist in determining who might develop early-onset preeclampsia, while others help in diagnosing severe cases—a variant known for its potentially devastating outcomes for both mothers and infants. These innovations, however, add to an already limited arsenal available to healthcare professionals dealing with a pregnancy complication that poses real threats to maternal and fetal health.
The Preeclampsia Foundation involved its Medical Advisory Board, composed of top experts in predictive and diagnostic testing, as well as patient advisors in the development of these educational materials, ensuring they are rooted in evidence-based, patient-centric content.
For patients seeking information on preeclampsia testing, they can visit Preeclampsia's Patient Testing Resources. Healthcare providers can access resources tailored to their needs via Preeclampsia's Provider Testing Resources.
Established in 2000, the Preeclampsia Foundation is a U.S.-based non-profit organization dedicated to enhancing outcomes for those grappling with hypertensive disorders of pregnancy. Their goal is to educate, support, and engage the community while fostering improved healthcare practices and ultimately finding a cure for preeclampsia. Their vision is a world in which preeclampsia and related disorders do not pose risks to the lives of mothers and their babies. For more details about their initiatives, visit www.preeclampsia.org.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.